Filing Details

Accession Number:
0001708138-20-000102
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-27 16:23:04
Reporting Period:
2020-08-25
Accepted Time:
2020-08-27 16:23:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225471 L George Sing 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-25 12,750 $273.67 97,165 No 4 M Direct
Common Stock Disposition 2020-08-25 1,400 $600.36 95,765 No 4 S Direct
Common Stock Disposition 2020-08-25 300 $601.75 95,465 No 4 S Direct
Common Stock Disposition 2020-08-25 400 $602.68 95,065 No 4 S Direct
Common Stock Disposition 2020-08-25 3,000 $603.53 92,065 No 4 S Direct
Common Stock Disposition 2020-08-25 3,705 $604.43 88,360 No 4 S Direct
Common Stock Disposition 2020-08-25 4,700 $605.53 83,660 No 4 S Direct
Common Stock Disposition 2020-08-25 5,168 $606.43 78,492 No 4 S Direct
Common Stock Disposition 2020-08-25 2,384 $607.46 76,108 No 4 S Direct
Common Stock Disposition 2020-08-25 300 $608.06 75,808 No 4 S Direct
Common Stock Disposition 2020-08-25 760 $609.67 75,048 No 4 S Direct
Common Stock Disposition 2020-08-25 3,793 $610.42 71,255 No 4 S Direct
Common Stock Disposition 2020-08-25 3,840 $611.60 67,415 No 4 S Direct
Common Stock Disposition 2020-08-25 1,900 $612.43 65,515 No 4 S Direct
Common Stock Disposition 2020-08-25 800 $613.39 64,715 No 4 S Direct
Common Stock Disposition 2020-08-25 300 $614.15 64,415 No 4 S Direct
Common Stock Disposition 2020-08-25 1,000 $612.00 3,700 No 4 S Indirect by Trust for Son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect by Trust for Son
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-08-25 12,750 $0.00 12,750 $273.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-01-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,150 Indirect by Spouse
Common Stock 400 Indirect by Spouse/Cust Son
Footnotes
  1. Represents volume-weighted average price of sales of 1,400 shares of Company stock on August 25, 2020 at prices ranging from $600.04 to $600.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  2. Represents volume-weighted average price of sales of 300 shares of Company stock on August 25, 2020 at prices ranging from $601.64 to $601.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 400 shares of Company stock on August 25, 2020 at prices ranging from $602.05 to $602.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 3,000 shares of Company stock on August 25, 2020 at prices ranging from $603.02 to $603.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 3,705 shares of Company stock on August 25, 2020 at prices ranging from $604.00 to $604.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 4,700 shares of Company stock on August 25, 2020 at prices ranging from $605.00 to $605.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 5,168 shares of Company stock on August 25, 2020 at prices ranging from $606.05 to $606.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 2,384 shares of Company stock on August 25, 2020 at prices ranging from $607.13 to $607.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 760 shares of Company stock on August 25, 2020 at prices ranging from $609.15 to $609.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  10. Represents volume-weighted average price of sales of 3,793 shares of Company stock on August 25, 2020 at prices ranging from $610.00 to $610.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  11. Represents volume-weighted average price of sales of 3,840 shares of Company stock on August 25, 2020 at prices ranging from $611.14 to $611.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  12. Represents volume-weighted average price of sales of 1,900 shares of Company stock on August 25, 2020 at prices ranging from $612.09 to $612.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  13. Represents volume-weighted average price of sales of 800 shares of Company stock on August 25, 2020 at prices ranging from $613.07 to $613.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  14. Represents volume-weighted average price of sales of 300 shares of Company stock on August 25, 2020 at prices ranging from $614.01 to $614.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price.
  15. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.